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ABSTRACT. Prions are the etiological agent of fatal neurodegenerative diseases called prion
diseases or transmissible spongiform encephalopathies. These maladies can be sporadic, genetic or
infectious disorders. Prions are due to post-translational modifications of the cellular prion protein
leading to the formation of a b-sheet enriched conformer with altered biochemical properties. The
molecular events causing prion formation in sporadic prion diseases are still elusive. Recently, we
published a research elucidating the contribution of major structural determinants and environmental
factors in prion protein folding and stability. Our study highlighted the crucial role of octarepeats in
stabilizing prion protein; the presence of a highly enthalpically stable intermediate state in prion-
susceptible species; and the role of disulfide bridge in preserving native fold thus avoiding the
misfolding to a b-sheet enriched isoform. Taking advantage from these findings, in this work we
present new insights into structural determinants of prion protein folding and stability.
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INTRODUCTION
Prion diseases or transmissible spongiform
encephalopathies (TSE) are a group of fatal neu-
rodegenerative diseases such as Creutzfeldt–
Jakob disease (CJD), Gerstmann–Str€aussler–
Scheinker (GSS) syndrome, fatal familial insom-
nia (FFI), and kuru in humans, bovine spongi-
form encephalopathy in cattle, scrapie in sheep
and goats, and chronic wasting disease in elk,
deer, and moose.1 These maladies can be spo-
radic, genetic or infectious disorders.2 Prions, the
etiological agents of these disorders, are com-
posed of a conformational isoform of cellular
prion protein (PrPC) known as PrPSc.3 Compared
to PrPC, prions present altered biochemical prop-
erties, such as resistance to limited proteolysis
and insolubility in non-denaturant detergents,
and secondary and tertiary structures. While
PrPC contains 40% a-helix and 3% b-sheet,
PrPSc is highly enriched in b-sheets. Fourier-
transform infrared spectroscopy analysis showed
higher b-sheet (43%) and lower a-helix (30%)
content in PrPSc than PrPC.4 The reduction of
a-helical content in PrPSc has been also con-
firmed by hydrogen-deuterium exchange experi-
ments showing no native a-helices in prions.5
Although the insoluble nature of prions hampers
the use of high-resolution analytical techniques
such as nuclear magnetic resonance or X-ray
crystallography, a number of studies using low
resolution approaches such as limited proteoly-
sis, Fourier transform infrared spectroscopy,
antibody-labeling, electron microscopy, fiber X-
ray diffraction and small angle X-ray scattering
provided important information on both second-
ary and tertiary PrPSc structure.6,7
According to the ‘protein-only hypothesis’,
the transmission of the disease is due to the
ability of a prion to convert PrPC into the patho-
logical form, acting as a template.8 During the
course of prion diseases, PrPC is converted into
the abnormal form by a conversion process
whereby most a-helix motives are replaced by
b-sheet secondary structures.7 Point mutations
and seeds trigger PrPC to overcome the energy
barriers, causing genetic and infectious TSE.9
Information on molecular events leading to
sporadic CJD is still lacking, though epidemio-
logical studies indicate being a majority of all
prion diseases.10 Understanding the molecular
mechanisms by which PrPC is converted into
PrPSc is a major challenge in prion research.
PRION PROTEIN STRUCTURE
AND FUNCTION
The PrPC is a sialoglycoprotein tethered to
the outer leaflet of the plasma membrane via a
C-terminal glycosylphosphatidylinositol (GPI)
anchor. Following the cleavage of N-terminal
signal peptide, PrPC is exported to the cell sur-
face as a N-glycosylated protein. Its tridimen-
sional structure is highly conserved among
mammals,11,12 and it is composed of a flexible
unfolded N-terminal domain and an a-helical
enriched globular domain (Fig. 1).13 The
unfolded N-terminal domain consists of
unusual glycine-rich repeats. Residues 59¡90
(mouse numbering) form 4 octarepeats (OR),
PHGG[GS]WGQ, while residues 51¡58 form
an octapeptide lacking of the histidine residue
(PQGGTWGQ). The OR segment binds copper
and other divalent cations such as zinc, nickel,
iron and manganese.14–18 Although PrPC and
metals share many common physiological
functions, such as neuroprotection against apo-
ptosis and oxidative stress, neurite outgrowth,
maintenance of myelinated axons, copper
homeostasis and synapse formation and func-
tioning, the role of PrPC¡metal complexes is
still elusive.19 Recently, the role of PrPC-cop-
per complex in protecting neurons by modulat-
ing NMDA receptor through S-nitrosylation
has been shown.20
The C-terminal domain presents 3 a-helices
(spanning residues 143¡152, 171¡192 and
199¡222), a short 2-stranded antiparallel
b-sheet, and a short C-terminal tail.13,21 The V-
shaped arrangement of the 2 longest helices,
the second and the third, forms the scaffold
onto which the b-sheet and the first a-helix are
anchored. This domain also contains a disulfide
bridge linking a2-a3 helices, and the 2 N-linked
carbohydrates.
Like many other cell surface proteins, PrPC
is exposed to low dielectric constant and differ-
ent pH values because of its proximity to mem-
branes and the constitutive cycling between
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plasma membrane and endocytic compart-
ments. As a general mechanism for modulating
its activity,22 PrPC can be differentially cleaved
in vivo in the central region generating a solu-
ble N-terminal domain and an anchored C-ter-
minal globular domain (truncated form).22–24
PRION PROTEIN FOLDING
AND STABILITY
PrPC is formed by several structural determi-
nants such as unfolded N-terminal domain,
octapeptide region, globular domain, and disul-
fide bridge. In physiological conditions PrPC
mostly folds in a-helical conformation,
whereas in prion pathogenesis it is converted
into the b-sheet enriched isoform PrPSc. To dis-
close molecular mechanisms inducing the path-
ological conversion in sporadic forms of prion
diseases, a detailed study on the major struc-
tural determinants and environmental key fac-
tors affecting prion protein folding and stability
is required. Recently, we published a study elu-
cidating the contribution of major structural
determinants and environmental factors in
prion protein folding and stability.25
Comparing folding of full-length and trun-
cated forms, we observed an a-helical confor-
mation for both proteins at neutral and acidic
pH, with the full-length more stable than the
truncated form. Calorimetric measurements on
full-length protein showed DG25C values 4–5
Kcal/mol higher than those obtained with spec-
troscopic analysis. Since calorimetry measures
the amount of released or absorbed heat during
chemical reactions and physical changes, tak-
ing into account all interactions occurring in
protein folding and unfolding, the higher
DG25C values obtained by differential
scanning calorimetry are due to the interaction
of N-terminal tail with C-terminal domain thus
suggesting a role for the unfolded N-terminal
domain in stabilizing the folded globular part.
The flexible N-terminal domain interacts with
the folded C-terminal part stabilizing it and
favoring its folding, as confirmed by the revers-
ible folding/unfolding process of full-length
and the fully irreversible thermal unfolding
transition of the truncated form. Therefore the
flexible tail of the protein affects folding and
stability of globular domain. The contribution
of N-terminal domain in stabilizing the protein
is pH-dependent because of histidine residues
in the OR part acting as pH sensor. At acidic
conditions similar to those present in endocytic
compartments, histidine residues are mostly
positively charged and stability of full-length is
reduced. Also in these conditions, full-length is
more stable than the truncated form, as indi-
cated by [Urea]1/2 value of 5.7 M and 5.2 M
respectively.
As describe above, OR segment represents
the major structural determinant in N-termi-
nal domain. In addition to metal binding, OR
region is involved in stabilizing full-length
protein, preserving its native folding. The
lack of only one octarepeat causes the
decrease of a-helical content and determines
the loss of reversibility, similarly to the trun-
cated form. To conclude, the N-terminal
domain modulates the stability of C-terminal
domain through the OR segment. Aberrant
interactions of N-terminal domain with
surrounding proteins or molecules, such as
divalent cations, may alter the stabilizing
effect on the globular domain permitting its
misfolding. Metal dys-homeostasis may
therefore induce the formation of non-physi-
ological PrPC-metal complexes, aberrant
FIGURE 1. Schematic representation of PrPC structural determinants. Highlighted: N-terminal
domain (red line), globular domain (blue line), octarepeat region (OR) with octapeptide sequences
(see main text), a-helices (H1, H2 and H3), b-strands (S1, S2), N-linked glycosylation sites (CHO),
disulfide bridges (S-S) and glycosylphosphatidylinisotol (GPI) anchor.
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N-terminal/C-terminal interactions and then
globular domain destabilization.
The cleavage of PrPC by zinc metallopro-
tease ADAM family induces the release of N-
terminal domain and the formation of the trun-
cated form. This globular domain is still teth-
ered to membrane and undergoes to the
constitutive cycling between plasma membrane
and endosomes, with subsequent exposure to
different environmental pH values. In the pres-
ence of acidic conditions, globular domain
unfolds with a 3-state transition mechanism.
The transition state is favored at low tempera-
tures, as confirmed by free-energy and [Urea]1/
2 values, and it is enthalpically stabilized with
respect to the native state by approximately 20
kcal/mol. Interestingly, the highly enthalpically
stable intermediate state corresponds to a pecu-
liar metastable folding of PrP only in species
susceptible to scrapie such as human, mouse,
cattle, and some sheep variants. Scrapie-resis-
tant species, as the sheep variant ARR, do not
show the highly enthalpically stable intermedi-
ate state. Therefore, this metastable state may
represent a common path in the pathological
conversion of PrPC to PrPSc. This finding is in
agreement with previous observations show-
ing the endosomal recycling compartment as
the intracellular site of the conversion.26 The
highly enthalpically stable intermediate state
is characterized by a repositioning of a1-
helix, a new b-sheet between residues 124–
128 and residues 151–155, and a larger num-
ber of intramolecular salt-bridges and inter-
molecular hydrogen bonds with water not
accessible from the native conformation. The
structural rearrangements leading to the for-
mation of the metastable state are compatible
with results obtained with low resolution
techniques on N-terminally truncated PrP27–
30,6,7 and the left-handed b-helix model pro-
posed by Govaerts et al.27 In this model, PrP
residues from 90 to 170 are converted into
b-strands and subsequently in b-helices,
while the globular domain retains its a-heli-
cal structure with the disulfide bridge and
the glycan moieties located outside the olig-
omeric core.
FIGURE 2. Cartoon of the major structural determinants and environmental key factors in prion
protein folding and stability. Abbreviations correspond to: cellular prion protein (PrPC); prion
(PrPSc); highly enthalpically stable intermediate state (IS); plasma membrane (PM); endosomial
vesicles (EV); disulfide bridge (R-S-S-R); free thiol (R-SH).
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TSE, as other neurodegenerative diseases,
are characterized by oxidative damage.28–30
The impact of oxidative stress on PrPC disulfide
bridge and then on prion conversion is
unsolved. For this reason, we investigated the
role of disulfide bridge in preserving native
folding and protein stability. Previously pub-
lished in vitro studies have shown that disulfide
bridge reduction under denaturing conditions
causes the disruption of native tertiary interac-
tions and protein unfolding. In our study, we
reduced disulfide bridge in quasi-native condi-
tions, preserving protein folding. While the
reduced form of full-length shows a decrease in
a-helical content, the reduced globular domain
is characterized by larger b-sheet content and
hydrophobic surface exposed to the solvent.
The increased hydrophobicity on protein sur-
face leads to misfolding and aggregation.
CONCLUSIONS
During prion pathogenesis, PrPC undergoes
to structural rearrangements leading to the for-
mation of prions. Prions propagate acting as a
template, and thus converting new PrPC mole-
cules into PrPSc. In sporadic forms of prion dis-
eases, the early events causing PrPC misfolding
and conversion are still unclear. Understanding
the major structural determinants in PrPC fold-
ing and stability is crucial to disclose the early
events leading to prion conversion in sporadic
TSE. In our study, we identified the structural
elements and environmental key factors in
prion protein folding and stability (Fig. 2).
These findings allow us to conclude that aber-
rant N-terminal domain/C-terminal domain
interactions or PrPC cleavage may cause pro-
tein misfolding in endosomial vesicles, there-
fore favoring prion conversion.
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